Terms: = Breast cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776
229 results:
1. Application research of radiomics in colorectal cancer: A bibliometric study.
Yang L; Wang B; Shi X; Li B; Xie J; Wang C
Medicine (Baltimore); 2024 Apr; 103(15):e37827. PubMed ID: 38608072
[TBL] [Abstract] [Full Text] [Related]
2. Who can benefit from postmastectomy radiotherapy among HR+/HER2- T1-2 N1M0 breast cancer patients? An explainable machine learning mortality prediction based approach.
Jin L; Zhao Q; Fu S; Zhang Y; Wu S; Li X; Cao F
Front Endocrinol (Lausanne); 2024; 15():1326009. PubMed ID: 38375194
[TBL] [Abstract] [Full Text] [Related]
3.
Bao S; Sun N; Li Y; Shu J; Xu J; Zhang Y; Qiu X
J Int Med Res; 2024 Jan; 52(1):3000605231223426. PubMed ID: 38263931
[TBL] [Abstract] [Full Text] [Related]
4. breast lesion morphology assessment with high and standard b values in diffusion-weighted imaging at 3 Tesla.
Christner SA; Grunz JP; Schlaiß T; Curtaz C; Kunz AS; Huflage H; Patzer TS; Bley TA; Sauer ST
Magn Reson Imaging; 2024 Apr; 107():100-110. PubMed ID: 38246517
[TBL] [Abstract] [Full Text] [Related]
5. Adherence Rate to Alliance for Clinical Trials in Oncology Z0011 Trial Based on breast cancer Subtype.
Maramara T; Hsieh MC; Janjua M; Li T; Wu XC; Williams M; Shoup M; Chu QD
J Am Coll Surg; 2024 Apr; 238(4):656-667. PubMed ID: 38193547
[TBL] [Abstract] [Full Text] [Related]
6. Sialic acid in human milk and infant formulas in China: concentration, distribution and type.
Lv Y; Wang X; Huang J; Zhang W; Zhu M; Dekyi K; Zhang Y; Zheng L; Li H
Br J Nutr; 2024 May; 131(9):1506-1512. PubMed ID: 38178715
[TBL] [Abstract] [Full Text] [Related]
7. Cholesterol-modified prognostic nutritional index (CPNI) as an effective tool for assessing the nutrition status and predicting survival in patients with breast cancer.
Shi J; Liu T; Ge Y; Liu C; Zhang Q; Xie H; Ruan G; Lin S; Zheng X; Chen Y; Zhang H; Song M; Zhang X; Hu C; Li X; Yang M; Liu X; Deng L; Shi H
BMC Med; 2023 Dec; 21(1):512. PubMed ID: 38129842
[TBL] [Abstract] [Full Text] [Related]
8. Patterns of Anticoagulation Use and All-Cause of Mortality in cancer Patients with Atrial Fibrillation.
Han X; Yang X; Hidru TH; Wang C; Xia Y
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):244-253. PubMed ID: 38088911
[TBL] [Abstract] [Full Text] [Related]
9. Mammography-based deep learning model for coronary artery calcification.
Ahn S; Chang Y; Kwon R; Kang J; Choi J; Lim GY; Kwon MR; Ryu S; Shin J
Eur Heart J Cardiovasc Imaging; 2024 Mar; 25(4):456-466. PubMed ID: 37988168
[TBL] [Abstract] [Full Text] [Related]
10. breast Imaging Patient Demographics at a Major Comprehensive cancer Center Before and During the COVID-19 Pandemic.
Cohen EO; Edelkamp P; Sun J; Leung JWT
J Am Coll Radiol; 2024 Apr; 21(4):576-588. PubMed ID: 37952808
[TBL] [Abstract] [Full Text] [Related]
11. Effect of chemotherapy and different chemotherapy regimens on bone health among Chinese breast cancer women in different menstrual status: a self-control study.
Peng BQ; Wu J; Tian S; Qu XQ; Liang XY; Feng JH; Chen YL; She RL; Ma CY; Song JY; Li ZX; Jiang ZY; Wu KN; Kong LQ
Support Care Cancer; 2023 Aug; 31(9):540. PubMed ID: 37642751
[TBL] [Abstract] [Full Text] [Related]
12. Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial.
Rugo HS; Bardia A; Marmé F; Cortés J; Schmid P; Loirat D; Trédan O; Ciruelos E; Dalenc F; Gómez Pardo P; Jhaveri KL; Delaney R; Valdez T; Wang H; Motwani M; Yoon OK; Verret W; Tolaney SM
Lancet; 2023 Oct; 402(10411):1423-1433. PubMed ID: 37633306
[TBL] [Abstract] [Full Text] [Related]
13. Cost-effectiveness of Trastuzumab Deruxtecan for HER2-low Advanced breast cancer in the United States.
Peng Y; Wang L; Peng L; Liu Q; Yi L; Luo X; Li S; Qin S; Wan X; Tan C; Chen G
Clin Ther; 2023 Oct; 45(10):965-972. PubMed ID: 37537015
[TBL] [Abstract] [Full Text] [Related]
14. Germline Mutations in 12 Genes and Risk of Ovarian cancer in Three Population-Based Cohorts.
Kotsopoulos J; Hathaway CA; Narod SA; Teras LR; Patel AV; Hu C; Yadav S; Couch FJ; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1402-1410. PubMed ID: 37493628
[TBL] [Abstract] [Full Text] [Related]
15. An Australian-based nomogram predicting nodal positivity for breast cancer in older patients.
Ofri A; Bhimani N; Warrier S
Surgeon; 2023 Dec; 21(6):e316-e322. PubMed ID: 37419764
[TBL] [Abstract] [Full Text] [Related]
16. Analytic Hierarchy Process Analysis of Patient Preferences for Contrast-Enhanced Mammography Versus MRI as Supplemental Screening Options for breast cancer.
Berg WA; Bandos AI; Sava MG
J Am Coll Radiol; 2023 Aug; 20(8):758-768. PubMed ID: 37394083
[TBL] [Abstract] [Full Text] [Related]
17. The diagnostic value of BI-RADS grade 3 to 5 for breast masses is correlated with the expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2.
He T; Shi T; Luo W; Ju Y; Li R
Medicine (Baltimore); 2023 Jun; 102(26):e33208. PubMed ID: 37390283
[TBL] [Abstract] [Full Text] [Related]
18. Impact of Beta Blockers on breast cancer Incidence and Prognosis.
Yang J; Zhang S; Jiang W
Clin Breast Cancer; 2023 Aug; 23(6):664-671.e21. PubMed ID: 37353431
[TBL] [Abstract] [Full Text] [Related]
19. Different Types of Patient Health Information Associated With Physician Decision-making Regarding cancer Screening Cessation for Older Adults.
Schoenborn NL; Boyd CM; Pollack CE
JAMA Netw Open; 2023 May; 6(5):e2313367. PubMed ID: 37184836
[TBL] [Abstract] [Full Text] [Related]
20. Variable Accessibility to Consumer Pricing Among breast cancer Operations.
Moon T; Bloom J; Youssef G; Gaffney K; Wareham C; Ganeshbabu N; Pawlak N; Hall J; Nardello S; Chatterjee A
Ann Surg Oncol; 2023 Aug; 30(8):4631-4635. PubMed ID: 37067741
[TBL] [Abstract] [Full Text] [Related]
[Next]
